These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 30050135)
1. Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways. Cao J; Lv W; Wang L; Xu J; Yuan P; Huang S; He Z; Hu J Cell Death Dis; 2018 Jul; 9(8):817. PubMed ID: 30050135 [TBL] [Abstract][Full Text] [Related]
2. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway. Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway. Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206 [TBL] [Abstract][Full Text] [Related]
4. Ricolinostat (ACY-1215) inhibits VEGF expression via PI3K/AKT pathway and promotes apoptosis in osteoarthritic osteoblasts. Li L; Liu F; Huang W; Wang J; Wan Y; Li M; Pang Y; Yin Z Biomed Pharmacother; 2019 Oct; 118():109357. PubMed ID: 31548177 [TBL] [Abstract][Full Text] [Related]
5. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression. Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway. Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164 [TBL] [Abstract][Full Text] [Related]
7. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines. Ma J; Guo X; Zhang S; Liu H; Lu J; Dong Z; Liu K; Ming L Mol Med Rep; 2015 Jun; 11(6):4525-31. PubMed ID: 25634603 [TBL] [Abstract][Full Text] [Related]
8. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo. Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway. Ma S; Liu T; Xu L; Wang Y; Zhou J; Huang T; Li P; Liu H; Zhang Y; Zhou X; Cui Y; Zang X; Wang Y; Guan F J Cell Physiol; 2019 Dec; 234(12):22400-22410. PubMed ID: 31120582 [TBL] [Abstract][Full Text] [Related]
10. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway. Shen Z; Xu L; Li J; Zhang N Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955 [TBL] [Abstract][Full Text] [Related]
11. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400 [TBL] [Abstract][Full Text] [Related]
12. ACY 1215, a histone deacetylase 6 inhibitor, inhibits cancer cell growth in melanoma. Wang F; Zhong BW; Zhao ZR J Biol Regul Homeost Agents; 2018; 32(4):851-858. PubMed ID: 30043566 [TBL] [Abstract][Full Text] [Related]
13. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis. Zhang W; Lei C; Fan J; Wang J Biochem Biophys Res Commun; 2016 Aug; 477(1):144-149. PubMed ID: 27291152 [TBL] [Abstract][Full Text] [Related]
14. MiR-34a reverses radiation resistance on ECA-109 cells by inhibiting PI3K/AKT/mTOR signal pathway through downregulating the expression of SIRT1. Ye Z; Xie T; Yan F; Wang L; Fang J; Wang Z; Hu F; Wang F; Fu Z Int J Radiat Biol; 2021; 97(4):452-463. PubMed ID: 33507132 [TBL] [Abstract][Full Text] [Related]
15. Liquiritigenin Induces Cell Cycle Arrest and Apoptosis in Lung Squamous Cell Carcinoma. Liu Y; Wang Y; Yang Y; Quan Y; Guo M Cell Biochem Biophys; 2024 Jun; 82(2):1397-1407. PubMed ID: 38775930 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma. Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206 [TBL] [Abstract][Full Text] [Related]
17. Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling. Zhu DS; Dong JY; Xu YY; Zhang XT; Fu SB; Liu W Med Sci Monit; 2020 Aug; 26():e927106. PubMed ID: 32804918 [TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma. Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945 [TBL] [Abstract][Full Text] [Related]
19. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma. Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756 [TBL] [Abstract][Full Text] [Related]
20. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways. Jiang JH; Pi J; Jin H; Cai JY J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]